613 results on '"López-Campos, José Luis"'
Search Results
2. Correction: Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry
3. Prevalence of genetic mutations in alpha-1 antitrypsin deficiency (aatd) in patients with chronic obstructive pulmonary disease in Colombia
4. Triple Therapy and Clinical Control in B+ COPD Patients: A Pragmatic, Prospective, Randomized Trial
5. Heteroatom-tagged proteomics of lung cancer and chronic obstructive pulmonary disease human serum reveal alterations in selenoproteins
6. Sex-Differences in Alpha-1 Antitrypsin Deficiency: Data From the EARCO Registry
7. Risk of lung disease in the PI*SS genotype of alpha-1 antitrypsin: an EARCO research project
8. Inhaled Maintenance Therapy in the Follow-Up of COPD in Outpatient Respiratory Clinics. Factors Related to Inhaled Corticosteroid Use. EPOCONSUL 2021 Audit
9. Resultados de la implementación de un programa de detección de casos de déficit de alfa-1 antitripsina en pacientes con EPOC
10. Variations in Chronic Obstructive Pulmonary Disease Outpatient Care in Respiratory Clinics: Results From the 2021 EPOCONSUL Audit
11. Evaluation of the Diagnostic Accuracy of Non-Specific Bronchial Provocation Tests in the Diagnosis of Asthma: A Randomized Cross-Over Study
12. Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry
13. CFTR dysfunction and targeted therapies: A vision from non-cystic fibrosis bronchiectasis and COPD
14. [Translated article] Spanish COPD Guideline (GesEPOC) Update: Comorbidities, Self-Management and Palliative Care
15. [Translated article] Spanish COPD Guidelines (GesEPOC 2021): Non-pharmacological Treatment Update
16. Actualización de la Guía Española de la EPOC (GesEPOC): comorbilidades, automanejo y cuidados paliativos
17. Actualización 2021 de la Guía Española de la EPOC (GesEPOC). Tratamiento no farmacológico
18. [Translated article] Spanish COPD Guidelines (GesEPOC) 2021 Update. Diagnosis and Treatment of COPD Exacerbation Syndrome
19. Actualización 2021 de la guía española de la EPOC (GesEPOC). Diagnóstico y tratamiento del síndrome de agudización de la EPOC
20. [Translated article] Spanish COPD guidelines (GesEPOC) 2021: Updated pharmacological treatment of stable COPD
21. [Translated article] Deconstructing phenotypes in COPD: An analysis of the TRACE cohort
22. Actualización 2021 de la Guía Española de la EPOC (GesEPOC). Tratamiento farmacológico de la EPOC estable
23. Deconstruyendo los fenotipos en la EPOC: un análisis de la cohorte TRACE
24. The long-term sequelae of COVID-19: an international consensus on research priorities for patients with pre-existing and new-onset airways disease
25. Knowledge of chronic obstructive pulmonary disease, presence of chronic respiratory symptoms and use of spirometry among the Spanish population: CONOCEPOC 2019 study
26. Conocimiento de la enfermedad pulmonar obstructiva crónica, presencia de síntomas respiratorios crónicos y uso de la espirometría en la población española: estudio CONOCEPOC 2019
27. COPD: systemic proteomic profiles in frequent and infrequent exacerbators
28. Global mortality and readmission rates following COPD exacerbation-related hospitalization: a meta-analysis of 65945 individual patients
29. Detection of Alpha-1 Antitrypsin Levels in Chronic Obstructive Pulmonary Disease in Respiratory Clinics in Spain: Results of the EPOCONSUL 2021 Audit
30. Evaluation of bone metabolism in children with cystic fibrosis
31. Recomendaciones SEPAR sobre la vacuna COVID-19 en las enfermedades respiratorias
32. The Beginning of the Trend Change in Lung Cancer Mortality Trends in Spain, 1980–2018
33. Results of a Diagnostic Procedure Based on Multiplex Technology on Dried Blood Spots and Buccal Swabs for Subjects With Suspected Alpha1 Antitrypsin Deficiency
34. Comparaciones entre asociaciones de broncodilatadores de larga duración para la enfermedad pulmonar obstructiva crónica
35. Documento de consenso sobre el diagnóstico y tratamiento de la infección bronquial crónica en la enfermedad pulmonar obstructiva crónica
36. Occult cancer in patients with unprovoked venous thromboembolism: A nested case-control study.
37. Soporte telefónico al paciente con EPOC en tiempos de la COVID-19
38. The clinical implications of triple therapy in fixed-dose combination in COPD: from the trial to the patient
39. Implicaciones clínicas del uso de la triple terapia en combinación de dosis fija en EPOC: del ensayo al paciente
40. Untargeted Metabolomic Study of Lung Cancer Patients after Surgery with Curative Intent
41. Metallomic Signatures of Lung Cancer and Chronic Obstructive Pulmonary Disease
42. Mortality and readmission after COPD exacerbation-related hospitalization: an individual patient data meta-analysis
43. Determinants of the Appearance and Progression of Early-Onset Chronic Obstructive Pulmonary Disease in Young Adults. A Case–Control Study With Follow-Up
44. EARLY COPD: determinantes de la aparición y progresión de la enfermedad pulmonar obstructiva crónica en adultos jóvenes. Protocolo de un estudio caso-control con seguimiento
45. The BIOMEPOC Project: Personalized Biomarkers and Clinical Profiles in Chronic Obstructive Pulmonary Disease
46. Proyecto de biomarcadores y perfiles clínicos personalizados en la enfermedad pulmonar obstructiva crónica (proyecto BIOMEPOC)
47. Characteristics of COPD Patients Managed in Respiratory Medicine Departments in Spain, According to GOLD Groups and GesEPOC Clinical Phenotypes
48. Características de los pacientes con EPOC tratados en neumología en España según grupos GOLD y fenotipos clínicos GesEPOC
49. Recommendations for the Implementation of the Self-Administration of Alpha-1 Antitrypsin
50. Smoking and COPD Knowledge in the General Spanish Population: A CONOCEPOC Study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.